GlassScriptPhysician profile
Thaddeus Rogozinski, II
NPI 1134879760
$1,998.19
in general payments reported to CMS, 2019-2025
7 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $351 · 2023: $121 · 2024: $1,016 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $647.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2024 | |
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Davol INC. | $282.86 | 2025 | Progel Applicator Spray Tips, Phasix Mesh |
| Ethicon US, LLC | $249.96 | 2022-2025 | Stratafix, Surgicel Nu-Knit, Evarrest |
| Solventum Corporation | $85.70 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
| Boston Scientific Corporation | $49.67 | 2023 | Spyglass |
| Integra Lifesciences Corporation | $25.00 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thaddeus Rogozinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.